pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    Carboplatin Pfizer
    Carboplatin
    Metastatic Ovarian Cancer$PFE PFIZER INC2 cat
  • Marketed
    DASATINIB
    DASATINIB
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Xspray Pharma AB2 cat
  • Marketed
    LENALIDOMIDE
    LENALIDOMIDE
    Follicular Lymphoma Bristol-Myers Squibb Co2 cat
  • Marketed
← prev
page 4 of 62
next →
Pain89
Neurology1
NELARABINE
NELARABINE
no indication
$AMRX Amneal Pharmaceuticals, Inc.
2 cat
  • Marketed
    Onureg
    Onureg (azacitidine)
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Bristol-Myers Squibb Co2 cat
  • Marketed
    TOREMIFENE CITRATE
    TOREMIFENE CITRATE
    Metastatic Breast Cancer Rising Pharma Holdings Inc2 cat
  • Marketed
    cosibelimab
    Unloxcyt (cosibelimab-ipdl)
    Cutaneous Squamous Cell Carcinoma (cSCC) Checkpoint Therapeutics Inc2 cat
  • Marketed
    denosumab biosimilar
    Jubereq (denosumab-dssb)
    Post Menopausal Osteoporosis Luye Pharma Group Ltd2 cat
  • pre_registration
    durvalumab
    Imfinzi (durvalumab)
    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…$AZN ASTRAZENECA PLC2 cat
  • Marketed
    imetelstat sodium
    Rytelo (imetelstat sodium)
    Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)$GERN GERON CORP2 cat
  • Marketed
    ipilimumab
    Yervoy (ipilimumab)
    Esophageal Squamous Cell Carcinoma (ESCC) Bristol-Myers Squibb Co2 cat
  • Marketed
    lenvatinib mesylate
    Lenvima (lenvatinib mesylate)
    Renal Cell Carcinoma Eisai Co Ltd2 cat
  • Marketed
    revumenib citrate
    Revuforj (revumenib citrate)
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…$SNDX Syndax Pharmaceuticals Inc2 cat
  • Marketed
    tarlatamab
    Imdelltra (tarlatamab-dlle)
    Small-Cell Lung Cancer$AMGN AMGEN INC2 cat
  • Phase 2
    teverelix
    teverelix [INN]
    Prostate Cancer Antev Ltd2 cat
  • Marketed
    zongertinib
    Hernexeos (zongertinib)
    Non-Small Cell Lung Cancer Boehringer Ingelheim Corp2 cat
  • Marketed
    Bortezomib Pfizer
    Bortezomib
    Mantle Cell Lymphoma Hospira Inc1 cat
  • Phase 1
    CK-0804
    Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis) Cellenkos Inc1 cat
  • Marketed
    CLADRIBINE
    CLADRIBINE
    Relapsing Remitting Multiple Sclerosis (RRMS) EMD Serono Inc1 cat
  • Marketed
    DECITABINE
    DECITABINE
    Chronic Myelomonocytic Leukemia (CMML) Mylan Institutional Inc1 cat
  • Phase 1
    EBTATE
    Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) Molecular Targeting Technologies Inc1 cat
  • Phase 3
    HLX-43
    Squamous Non-Small Cell Lung Cancer Shanghai Henlius Biotech Inc1 cat
  • Marketed
    HYDROCORTISONE SODIUM SUCCINATE
    HYDROCORTISONE SODIUM SUCCINATE
    Giant Cell Arteritis (Temporal Arteritis/Cranial Arteriti… Cipla USA Inc1 cat
  • Marketed
    IDELALISIB
    IDELALISIB
    Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma)$GILD GILEAD SCIENCES, INC.1 cat
  • Marketed
    Jelmyto
    Jelmyto (mitomycin)
    Transitional Cell Carcinoma (Urothelial Cell Carcinoma)$URGN UroGen Pharma Ltd.1 cat
  • Marketed
    LOMUSTINE
    LOMUSTINE
    Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Carnegie Pharmaceuticals LLC1 cat
  • Marketed
    NILOTINIB
    NILOTINIB
    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Xspray Pharma AB1 cat
  • Phase 2
    ONO-4578
    Metastatic Colorectal Cancer Bristol-Myers Squibb Co1 cat
  • Phase 1
    RP-72
    Metastatic Pancreatic Cancer Rise Biopharmaceutical Ltd1 cat
  • pre_registration
    apatinib mesylate
    CAM-RIVO (apatinib mesylate)
    Hepatocellular Carcinoma Elevar Therapeutics Inc1 cat